2/18/2013

A round of Series D financing has brought in $17 million for Cohera Medical. The Pittsburgh company aims to use the funding to expand its TissuGlu Surgical Adhesive in Europe as well as finance a no-drain clinical trial involving the device in the U.S.

Related Summaries